cours de bourse
14/08/2009 - 11:07:23|49.66 EUR 0.42 %
Stallergenes, Inc. is located in a first class office space in a...
Stallergenes is a World Leader in Sublingual Immunotherapy
A major player in its field, Stallergenes has set itself the goal of working alongside health professionals to improve the management of severe respiratory allergy and ensure a long-term improvement in patients' quality of life.
The key to Stallergenes' know-how in terms of product development, raw material quality or the extraction and production process lies on its knowledge of allergens.
Drawing on this expertise, the biopharmaceutical company works constantly to improve its Research & Development activities, making Stallergenes a world leader in sublingual immunotherapy.